Preferred Name | Sitagliptin | |
Synonyms |
SITAGLIPTIN Sitagliptin |
|
Definitions |
An orally available, competitive, beta-amino acid-derived inhibitor of dipeptidyl peptidase 4 (DDP-4) with hypoglycemic activity. Sitagliptin may cause an increased risk in the development of pancreatitis. |
|
ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C73838 |
|
CAS_Registry |
486460-32-6 |
|
CHEBI_ID |
CHEBI:40237 |
|
Chemical_Formula |
C16H15F6N5O |
|
code |
C73838 |
|
Concept_In_Subset |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C173381 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C173383 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116978 |
|
Contributing_Source |
CTRP FDA |
|
DEFINITION |
An orally available, competitive, beta-amino acid-derived inhibitor of dipeptidyl peptidase 4 (DDP-4) with hypoglycemic activity. Sitagliptin may cause an increased risk in the development of pancreatitis. |
|
Display_Name |
Sitagliptin |
|
FDA_UNII_Code |
QFP0P1DV7Z |
|
FULL_SYN |
SITAGLIPTIN Sitagliptin |
|
Has_Salt_Form | ||
Has_Target | ||
label |
Sitagliptin |
|
Legacy Concept Name |
Sitagliptin |
|
Preferred_Name |
Sitagliptin |
|
prefixIRI |
Thesaurus:C73838 |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C1565750 |
|
subClassOf |